Effect of systemic ozone use on oxidative modification of lipids and proteins in the colon in experimental colitis
https://doi.org/10.52420/2071-5943-2022-21-5-26-32
Abstract
Introduction. The processes of free radical oxidation play a significant role in the pathogenesis of inflammatory bowel diseases. The aim of the work was to study the clinical status, the content of lipid peroxidation products, oxidative modification of proteins in the lesion of the colon in oxazole-induced colitis (OIC) under conditions of intraperitoneal application of ozone. Materials and methods. Wistar rats were modeled for OIC using oxazolone solution. Ozone-oxygen mixture (OX) was injected intraperitoneally once a day for six days. The clinic was assessed by disease activity index (DAI), the content of products of lipid peroxidation (LPO) and oxidative modification of proteins (OMB) was determined in colonic homogenate. Results. Under OIK DAI increases, the level of primary and secondary products in the heptane phase increases in the colonic homogenate; the level of secondary products and end products increased in the isopropanol phase. Under conditions of intraperitoneal application of ozone, DAI decreased, the level of isopropanol-soluble primary, secondary, final LPO products increased in colon homogenate on the 2nd day, the level of heptane- and isopropanol-soluble primary, secondary, final LPO products decreased on the 6th day, early and late LPO products decreased on the 4th, 6th day. We found a moderate and significant relationship on the Cheddock scale between DAI and the content of LPO and OMB products in the colonic homogenate mainly on day 6 of OIC under conditions of intraperitoneal application of ozone. Discussion. The increased content of LPO and OMB products in the lesion of the colon after the use of ozone is probably due to its mediated action (through the activation of ROS) and its ability to act as an oxidant of lipids and proteins of the cells of the mucosa of the colon. Conclusions. The positive effects of intraperitoneal application of ozone in OIC are the basis for further research in studying the mechanism of the protective effect of ozone with the possibility of further application in clinical conditions in inflammatory bowel diseases.
About the Authors
M. V. Osikov
South Ural State Medical University; Chelyabinsk Regional Clinical Hospital
Russian Federation
Russian Federation
Mikhail V. Osikov, Doctor of Science (Medicine), Professor
Chelyabinsk
N. V. Kaygorodtseva
South Ural State Medical University
Russian Federation
Russian Federation
Natalia V. Kaygorodtseva, Department Assistant
Chelyabinsk
References
1. Bek S., Nielsen J.V., Bojesen A.B. et al. Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases. Aliment Pharmacol Ther. 2016;44(6):554–567. https://doi.org/10.1111/apt.13736.
2. Burisch J., Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(8):942–951. https://doi.org/10.3109/00365521.2015.1014407.
3. Su H.J., Chiu Y.T., Chiu C.T. et al. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc. 2019;118(7):1083–1092. https://doi.org/10.1016/j.jfma.2018.07.005.
4. Белоусова Е.А., Абдулганиева Д.И., Алексеева О.П. с соавт. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018;46(5):445–463. https://doi.org/10.18786/2072-0505-2018-46-5-445-463.
5. Himuro H. The effect of ozone on colonic epithelial cells. Kurume Med J. 2018;64(4):75–81. https://doi.org/10.2739/kurumemedj.MS644002.
6. Wallace K.L., Zheng L.B., Kanazawa Y., Shih D.Q. Immunopathology of inflammatory bowel disease. World Journal of Gastroenterology. 2014;20(1):6–21. https://doi.org/10.3748/wjg.v20.i1.6.
7. Alzoghaibi M.A. Concepts of oxidative stress and antioxidant defense in Crohn’s disease. World Journal of Gastroenterology. 2013;19(39):6540–6547. https://doi.org/10.3748/wjg.v19.i39.6540.
8. Tian T., Wang Z., Zhang J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid. Med. Cell. Longev. 2017;2017:4535194. https://doi.org/10.1155/2017/4535194.
9. Assadsangabi A., Evans C.A., Corfe B.M., Lobo A. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives. Gastroenterol Res Pract. 2019;2019:1426954.
10. Titz B., Gadaleta R.M., Lo Sasso G. et al. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification. Int J Mol Sci. 2018;19(9):2775–2796. https://doi.org/10.3390/ijms19092775.
11. Ashton J.J., Mossotto E., Ennis S., Beattie R.М. Personalising medicine in inflammatory bowel disease-current and future perspectives. Transl Pediatr. 2019;8(1):56–69. https://doi.org/10.21037/tp.2018.12.03.
12. Mittal M., Siddiqui M.R. Reactive Oxygen Species in Inflammation and Tissue Injury. Antioxidants & Redox Signaling. 2014;20(7):1126–1167.
13. Bocci V.A. Scientific and medical aspects of ozone therapy. State of the art. Archives of medical research. 2006;37:425–435.
14. Siniscalco D., Trotta M.C., Brigida A.L. et al. Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin. Biology (Basel). 2018;7(1).
15. Bai Z., Li H., Guo X. et al. Successful treatment of acute-on-chronic liver failure and hemolytic anemia with hepatoprotective drugs in combination with intravenous ozone without steroids: A case report. Intractable & rare diseases research. 2018;7(3):204–208.
16. Директива 2010/63/EU Европейского парламента и Совета Европейского Союза от 22 сентября 2010 года по охране животных, используемых в научных целях. СПб.: 2012.
17. Turner P.V., Brab Th., Pekow C., Vasbinde M.A. Administration of substances to laboratory animals: routes of administration and factors to consider. J. Am. Assoc. Lab. Anim. Sci. 2011;50(5):600–613.
18. Best W.R., Becktel J.M., Singleton J.W., Kern F.Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439–444.
19. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory investigation. 1993;69(2):238–249.
20. Kim J.J., Shajib M.S., Manocha M.M., Khan W.I. Investigating intestinal inflammation in DSS-induced model of IBD. Journal of visualized experiments. 2012;60. https://doi.org/10.3791/3678.
21. Hughes A. A simplified benzidine test with an evaluation of some faecal occult blood tests. British medical journal. 1952;2(4791):970–975.
22. Экспериментальное моделирование и лабораторная оценка адаптивных реакций организма / И.А. Волчегорский, И.И. Долгушин, О.Л. Колесников, В.Э. Ц ейликман. Челябинск: ЧелГПУ; 2000. 167 с.
23. Львовская Е.И., Волчегорский И.А., Шемяков С.Е., Лифшиц Р.И. Спектрофотометрическое определение конечных продуктов ПОЛ. Вопросы медицинской химии. 1991;4:92–93.
24. Способ комплексной оценки содержания продуктов окислительной модификации белков в тканях и биологических жидкостях: метод. рекомендации / РИОязГМУ; сост.: М.А. Фомина. Рязань, 2014. 60 c.
25. Viebahn-Haensler R., León Fernández O.S. Ozone in medicine. The low-dose ozone concept and its basic biochemical mechanisms of action in chronic inflammatory diseases. Int. J. Mol. Sci. 2021;22(15):7890. https://doi.org/10.3390/ijms22157890.
26. Wang Z., Zhang A., Meng W. et al. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol. 2018;835:82–93. https://doi.org/10.1016/j.ejphar.2018.07.059.
Review
For citations:
Osikov MV, Kaygorodtseva NV. Effect of systemic ozone use on oxidative modification of lipids and proteins in the colon in experimental colitis. Ural Medical Journal. 2022;21(5):26-32. (In Russ.) https://doi.org/10.52420/2071-5943-2022-21-5-26-32
Views:
192
Email this article 